The Drugs Controller General of India has granted permission to Serum Institute of India to manufacture its COVID-19 vaccine ‘Covishield’.
The Serum Institute of India, the world’s largest vaccine manufacturer, has tied up with AstraZeneca to manufacture Covishield.
As per the company, the ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a strong immune response in healthy adults aged 56-69 and those over 70 years of age.
According to reports, the manufacturer of the Covishield vaccine intends to charge Rs 200 per dose for the first 100 lakh shots that will be supplied to the government. However, the actual price for the vaccine might come around Rs 1,000 per dose.
The development comes a day after the DCGI approved the Oxford coronavirus vaccine and Bharat Biotech’s Covaxin, making it India’s first vaccines against the pandemic. Reportedly, both the drug firms have submitted data on their trial runs and both have been granted permission for “restricted use”.
(Internet Inputs)